Associate Alexandra Valenti discusses how a wave of patent eligibility decisions on diagnostic method claims has impacted the innovation in the biotechnology field.
Read the full article.
Related Content
- InsightAugust 14, 2024
FDA Platform Technology Draft Guidance Highlights Utility of Obscure Patent Term Extension Provision
- AlertAugust 2, 2024
USPTO Issues Further Guidance on AI-Related Patent Eligibility
- InsightJuly 25, 2024
The Rapid Rise of AI, in Five Charts
- AlertMay 22, 2024
The Appeals Review Panel’s In Re Xencor Decision: The USPTO Provides Its Position on Written Description and Means-Plus-Function Claims
- AlertMarch 12, 2024
USPTO’s New Guidance on AI-Assisted Inventions: The Impact on the Use of AI in the Life Sciences
- AlertFebruary 13, 2024
USPTO Issues New Guidance on Patenting AI-Assisted Inventions
- InsightJanuary 16, 2024
What’s Next for AI? Six Areas to Watch in 2024
- InsightNovember 30, 2023
How To Reduce the Risk of Copyright Infringement When Using Generative AI To Write Code
- Speaking EngagementsOctober 8, 2024 | 1:15 PM - 2:30 PM ET
ACI's 4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA
- Speaking EngagementsSeptember 24, 2024
Sedona Conference WG9/10 Annual Meeting 2024
- Press ReleaseAugust 27, 2024
The National Law Journal Honors Amadou Kilkenny Diaw as a DC Rising Star
- Awards and RankingsAugust 15, 2024
The Best Lawyers in America 2025 Recognizes 312 Goodwin Lawyers
- Press ReleaseAugust 9, 2024
Goodwin Accelerates Activity for Artificial Intelligence and Machine Learning Transactions in 2024
- Awards and RankingsAugust 7, 2024
Benchmark Litigation Names Fourteen Goodwin Partners to 40 & Under Hot List 2024
- Press ReleaseAugust 2, 2024
Memorable Acquired By Reddit
- Speaking EngagementsJuly 31, 2024 | 2:00 PM - 3:15 PM ET
ACS Webinar - Avoiding IP Own Goals in Drug Discovery: Best Practices for Obtaining (and Keeping) Your IP